By Nancy Lapid April 17 (Reuters) - Researchers have developed a modified version of the CRISPR gene-editing tool that in early laboratory experiments suggests it may have the potential to “silence” ...

The data to be presented show that Geminii's bioelectronic therapy slowed tumor growth, extended survival, and enhanced the activity of chemoradiation in multiple preclinical NSCLC models without ...

An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including ...

This roundup highlights the latest robotics innovations aimed at improving throughput, simplifying deployment and helping ...

A potential new cancer therapy developed at QIMR Berghofer has been acquired by Kazia Therapeutics, an oncology-focused drug ...

One of the most studied lifespan-extending drugs in animals has just failed its test on humans in a 13-week clinical trial co ...

Denver is forcing more red lights overnight on Federal and Alameda to slow speeders and cut late‑night crashes.

U.S. Defense Secretary Pete Hegseth has canceled nearly 100 research studies related to global warming and security.

A new milestone in industrial AI is unfolding on the factory floor. Siemens, working alongside NVIDIA and UK-based robotics firm Humanoid, has successfully deployed a humanoid robot inside a live ...

The odometer froze, but the engine kept running — here's why.

View Enlivex Ltd. ENLV stock quote prices, financial information, real-time forecasts, and company news from CNN.